|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
5000 |
0.30 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.38 |
5.16 |
-35.29 |
4 |
5 |
1 |
86 |
350.423 |
3 |
↓
|
Hi
High (pH 8-9.5)
|
4.38 |
4.76 |
-15.1 |
3 |
5 |
0 |
85 |
349.415 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.87 |
14.08 |
-11.57 |
0 |
2 |
0 |
22 |
327.427 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 4 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.79 |
-0.02 |
-8.52 |
1 |
3 |
0 |
28 |
313.404 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 13 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.89 |
10.56 |
-92.66 |
4 |
7 |
2 |
76 |
520.077 |
7 |
↓
|
Hi
High (pH 8-9.5)
|
5.89 |
11.26 |
-34.85 |
3 |
7 |
1 |
79 |
519.069 |
7 |
↓
|
Lo
Low (pH 4.5-6)
|
5.89 |
10.95 |
-151.63 |
5 |
7 |
3 |
77 |
521.085 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
400 |
0.26 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
3000 |
0.23 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.06 |
-4.67 |
-20.01 |
2 |
8 |
0 |
86 |
479.606 |
7 |
↓
|
|
|
Analogs
-
4809430
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.03 |
-8.58 |
-20.69 |
6 |
7 |
0 |
123 |
393.472 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 8 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KCNH2-2-E |
HERG (cluster #2 Of 5), Eukaryotic |
Eukaryotes |
210 |
0.33 |
Binding ≤ 10μM
|
S22A1-1-E |
Solute Carrier Family 22 Member 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5000 |
0.27 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
9940 |
0.25 |
Binding ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
720 |
0.31 |
Binding ≤ 10μM |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
ADO-1-E |
Aldehyde Oxidase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6400 |
0.26 |
ADME/T ≤ 10μM
|
CP2D6-2-E |
Cytochrome P450 2D6 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
7500 |
0.26 |
ADME/T ≤ 10μM
|
Z103205-3-O |
A431 (cluster #3 Of 4), Other |
Other |
5890 |
0.26 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
600 |
0.31 |
Functional ≤ 10μM
|
Z50460-4-O |
Leishmania Major (cluster #4 Of 4), Other |
Other |
1500 |
0.29 |
Functional ≤ 10μM
|
Z80064-8-O |
CCRF-CEM (T-cell Leukemia) (cluster #8 Of 9), Other |
Other |
139 |
0.34 |
Functional ≤ 10μM
|
Z80084-1-O |
CEM-VLB (Vinblastine-resistant T-cell Leukemia Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.31 |
Functional ≤ 10μM
|
Z80085-1-O |
CEM-VM1 (Etoposide-resistant T-cell Leukemia Cells) (cluster #1 Of 2), Other |
Other |
1910 |
0.29 |
Functional ≤ 10μM
|
Z80089-1-O |
CHO-AA8 (cluster #1 Of 2), Other |
Other |
1 |
0.45 |
Functional ≤ 10μM
|
Z80115-1-O |
DC3F (cluster #1 Of 1), Other |
Other |
4 |
0.42 |
Functional ≤ 10μM
|
Z80117-2-O |
DC3F/AD-II (cluster #2 Of 2), Other |
Other |
47 |
0.37 |
Functional ≤ 10μM
|
Z80152-1-O |
HCT-8 (Ileocecal Adenocarcinoma) (cluster #1 Of 2), Other |
Other |
120 |
0.35 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
6 |
0.41 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
559 |
0.31 |
Functional ≤ 10μM |
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
23 |
0.38 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
50 |
0.37 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
75 |
0.36 |
Functional ≤ 10μM
|
Z80227-2-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
1165 |
0.30 |
Functional ≤ 10μM
|
Z80244-7-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #7 Of 7), Other |
Other |
490 |
0.32 |
Functional ≤ 10μM
|
Z80322-1-O |
NCI-H358 (Lung Carcinama Cells) (cluster #1 Of 2), Other |
Other |
150 |
0.34 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
890 |
0.30 |
Functional ≤ 10μM
|
Z80475-3-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #3 Of 3), Other |
Other |
60 |
0.36 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
240 |
0.33 |
Functional ≤ 10μM
|
Z80608-4-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #4 Of 4), Other |
Other |
180 |
0.34 |
Functional ≤ 10μM
|
Z80612-1-O |
2008 (Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
4310 |
0.27 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
3520 |
0.27 |
Functional ≤ 10μM
|
Z80712-7-O |
T47D (Breast Carcinoma Cells) (cluster #7 Of 7), Other |
Other |
220 |
0.33 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
1485 |
0.29 |
Functional ≤ 10μM |
Z80846-2-O |
F460pv8/eto Cell Line (cluster #2 Of 2), Other |
Other |
40 |
0.37 |
Functional ≤ 10μM
|
Z80889-2-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
210 |
0.33 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
700 |
0.31 |
Functional ≤ 10μM
|
Z81024-8-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #8 Of 8), Other |
Other |
60 |
0.36 |
Functional ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
100 |
0.35 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
80 |
0.35 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
901 |
0.30 |
Functional ≤ 10μM |
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
9500 |
0.25 |
Functional ≤ 10μM
|
Z81252-10-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #10 Of 11), Other |
Other |
140 |
0.34 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
1010 |
0.30 |
Functional ≤ 10μM
|
Z81284-2-O |
NCI-H647 (cluster #2 Of 2), Other |
Other |
70 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.91 |
6.33 |
-44.52 |
2 |
6 |
0 |
84 |
393.468 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
4.91 |
5.83 |
-16.62 |
2 |
6 |
0 |
80 |
393.468 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
4.91 |
5.94 |
-47.33 |
1 |
6 |
-1 |
82 |
392.46 |
5 |
↓
|
|
|
|
|
Analogs
-
22065493
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 64 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AAK1-1-E |
Adaptor-associated Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4400 |
0.26 |
Binding ≤ 10μM
|
ABL1-1-E |
Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
770 |
0.30 |
Binding ≤ 10μM
|
ABL2-1-E |
Tyrosine-protein Kinase ABL2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
300 |
0.31 |
Binding ≤ 10μM
|
ADCK3-1-E |
Chaperone Activity Of Bc1 Complex-like, Mitochondrial (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1900 |
0.28 |
Binding ≤ 10μM
|
ADCK4-1-E |
Uncharacterized AarF Domain-containing Protein Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2500 |
0.27 |
Binding ≤ 10μM
|
ALK-1-E |
ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1200 |
0.29 |
Binding ≤ 10μM
|
AURKA-3-E |
Serine/threonine-protein Kinase Aurora-A (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
3800 |
0.26 |
Binding ≤ 10μM
|
AURKB-1-E |
Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.28 |
Binding ≤ 10μM
|
AURKC-1-E |
Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
600 |
0.30 |
Binding ≤ 10μM
|
BLK-1-E |
Tyrosine-protein Kinase BLK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
190 |
0.32 |
Binding ≤ 10μM
|
BMP2K-1-E |
BMP-2-inducible Protein Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1800 |
0.28 |
Binding ≤ 10μM
|
CTRO-1-E |
Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
680 |
0.30 |
Binding ≤ 10μM
|
DDR1-1-E |
Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
790 |
0.29 |
Binding ≤ 10μM
|
DMPK-1-E |
Myotonin-protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2900 |
0.27 |
Binding ≤ 10μM
|
E2AK2-1-E |
Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1300 |
0.28 |
Binding ≤ 10μM
|
E2AK4-1-E |
Eukaryotic Translation Initiation Factor 2-alpha Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4400 |
0.26 |
Binding ≤ 10μM
|
EGFR-3-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
51 |
0.35 |
Binding ≤ 10μM
|
EPHA3-1-E |
Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2400 |
0.27 |
Binding ≤ 10μM
|
EPHA6-1-E |
Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
930 |
0.29 |
Binding ≤ 10μM
|
EPHA7-1-E |
Ephrin Type-A Receptor 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.28 |
Binding ≤ 10μM
|
EPHA8-1-E |
Ephrin Type-A Receptor 8 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
940 |
0.29 |
Binding ≤ 10μM
|
ERBB2-2-E |
Receptor Protein-tyrosine Kinase ErbB-2 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
870 |
0.29 |
Binding ≤ 10μM
|
ERBB4-1-E |
Receptor Protein-tyrosine Kinase ErbB-4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1130 |
0.29 |
Binding ≤ 10μM
|
FGFR2-1-E |
Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1900 |
0.28 |
Binding ≤ 10μM
|
FGR-1-E |
Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1100 |
0.29 |
Binding ≤ 10μM
|
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
820 |
0.29 |
Binding ≤ 10μM
|
FRK-1-E |
Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2000 |
0.28 |
Binding ≤ 10μM
|
GAK-1-E |
Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
40 |
0.36 |
Binding ≤ 10μM
|
HCK-1-E |
Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1800 |
0.28 |
Binding ≤ 10μM
|
JAK3-2-E |
Tyrosine-protein Kinase JAK3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
930 |
0.29 |
Binding ≤ 10μM
|
KC1D-1-E |
Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3500 |
0.26 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3100 |
0.27 |
Binding ≤ 10μM
|
KS6A4-1-E |
Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7000 |
0.25 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
530 |
0.30 |
Binding ≤ 10μM
|
LTK-1-E |
Leukocyte Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
890 |
0.29 |
Binding ≤ 10μM
|
LYN-1-E |
Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
530 |
0.30 |
Binding ≤ 10μM
|
MET-1-E |
Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3800 |
0.26 |
Binding ≤ 10μM
|
MK04-1-E |
Mitogen-activated Protein Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2500 |
0.27 |
Binding ≤ 10μM
|
MK09-1-E |
C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4000 |
0.26 |
Binding ≤ 10μM
|
MKNK1-1-E |
MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
690 |
0.30 |
Binding ≤ 10μM
|
MKNK2-1-E |
MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1600 |
0.28 |
Binding ≤ 10μM
|
MRCKG-1-E |
Serine/threonine-protein Kinase MRCK Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3400 |
0.26 |
Binding ≤ 10μM
|
MYLK2-1-E |
Myosin Light Chain Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
970 |
0.29 |
Binding ≤ 10μM
|
PGFRA-1-E |
Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1800 |
0.28 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.28 |
Binding ≤ 10μM
|
RET-1-E |
Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
330 |
0.31 |
Binding ≤ 10μM
|
RIPK2-1-E |
Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
680 |
0.30 |
Binding ≤ 10μM
|
SLK-1-E |
Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
26 |
0.37 |
Binding ≤ 10μM
|
SRC-1-E |
Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
700 |
0.30 |
Binding ≤ 10μM
|
STK10-1-E |
Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
83 |
0.34 |
Binding ≤ 10μM
|
TBA1A-2-E |
Tubulin Alpha-3 Chain (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
230 |
0.32 |
Binding ≤ 10μM
|
TIE1-1-E |
Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
850 |
0.29 |
Binding ≤ 10μM
|
TNI3K-1-E |
Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
570 |
0.30 |
Binding ≤ 10μM
|
TNK1-1-E |
Non-receptor Tyrosine-protein Kinase TNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
630 |
0.30 |
Binding ≤ 10μM
|
TYRO3-1-E |
Tyrosine-protein Kinase Receptor TYRO3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3900 |
0.26 |
Binding ≤ 10μM
|
ULK3-1-E |
Serine/threonine-protein Kinase ULK3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
630 |
0.30 |
Binding ≤ 10μM
|
VGFR1-1-E |
Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4400 |
0.26 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2100 |
0.27 |
Binding ≤ 10μM
|
YES-1-E |
Tyrosine-protein Kinase YES (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2200 |
0.27 |
Binding ≤ 10μM
|
EGFR-1-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
19 |
0.37 |
Functional ≤ 10μM
|
ERBB2-2-E |
Receptor Protein-tyrosine Kinase ErbB-2 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
299 |
0.31 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
96 |
0.34 |
Functional ≤ 10μM
|
Z103348-1-O |
NCI-H2122 (cluster #1 Of 2), Other |
Other |
1000 |
0.29 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
6000 |
0.25 |
Functional ≤ 10μM
|
Z80475-3-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #3 Of 3), Other |
Other |
1560 |
0.28 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
270 |
0.32 |
Functional ≤ 10μM |
Z81020-7-O |
HepG2 (Hepatoblastoma Cells) (cluster #7 Of 8), Other |
Other |
80 |
0.34 |
Functional ≤ 10μM |
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2000 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.80 |
9.59 |
-15.77 |
1 |
7 |
0 |
75 |
393.443 |
10 |
↓
|
|
|
Analogs
-
1661
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z103204-1-O |
A427 (cluster #1 Of 4), Other |
Other |
5130 |
0.39 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
10000 |
0.37 |
Functional ≤ 10μM
|
Z50587-3-O |
Homo Sapiens (cluster #3 Of 9), Other |
Other |
3240 |
0.40 |
Functional ≤ 10μM
|
Z80008-2-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
310 |
0.48 |
Functional ≤ 10μM
|
Z80035-2-O |
B16 (Melanoma Cells) (cluster #2 Of 7), Other |
Other |
2200 |
0.42 |
Functional ≤ 10μM
|
Z80064-7-O |
CCRF-CEM (T-cell Leukemia) (cluster #7 Of 9), Other |
Other |
6170 |
0.38 |
Functional ≤ 10μM
|
Z80112-1-O |
DAN-G (cluster #1 Of 2), Other |
Other |
2650 |
0.41 |
Functional ≤ 10μM
|
Z80156-4-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #4 Of 12), Other |
Other |
2040 |
0.42 |
Functional ≤ 10μM
|
Z80193-10-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #10 Of 12), Other |
Other |
981 |
0.44 |
Functional ≤ 10μM
|
Z80211-2-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
4900 |
0.39 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
5700 |
0.39 |
Functional ≤ 10μM
|
Z80231-2-O |
MCF7S (Breast Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
300 |
0.48 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
3240 |
0.40 |
Functional ≤ 10μM
|
Z80362-3-O |
P388 (Lymphoma Cells) (cluster #3 Of 8), Other |
Other |
220 |
0.49 |
Functional ≤ 10μM
|
Z80473-1-O |
SISO (cluster #1 Of 2), Other |
Other |
1000 |
0.44 |
Functional ≤ 10μM
|
Z80604-1-O |
YAPC (cluster #1 Of 2), Other |
Other |
5950 |
0.39 |
Functional ≤ 10μM
|
Z80807-1-O |
D283 Cell Line (cluster #1 Of 1), Other |
Other |
6800 |
0.38 |
Functional ≤ 10μM
|
Z80874-3-O |
CEM (T-cell Leukemia) (cluster #3 Of 7), Other |
Other |
2500 |
0.41 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
5000 |
0.39 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2200 |
0.42 |
Functional ≤ 10μM
|
Z81235-1-O |
M4Beu Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.44 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
1900 |
0.42 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
5700 |
0.39 |
Functional ≤ 10μM
|
Z81338-1-O |
T-cells (cluster #1 Of 3), Other |
Other |
2200 |
0.42 |
Functional ≤ 10μM
|
Z80874-2-O |
CEM (T-cell Leukemia) (cluster #2 Of 4), Other |
Other |
2470 |
0.41 |
ADME/T ≤ 10μM
|
Z81325-1-O |
SR (Leukemia Cells) (cluster #1 Of 1), Other |
Other |
1860 |
0.42 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.08 |
6.61 |
-40.9 |
3 |
4 |
0 |
71 |
305.205 |
8 |
↓
|
|
|
Analogs
-
5138662
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
3000 |
0.29 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2000 |
0.30 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.98 |
-6.86 |
-16 |
4 |
6 |
0 |
97 |
378.457 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 26 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HDAH-1-B |
Histone Deacetylase-like Amidohydrolase (cluster #1 Of 2), Bacterial |
Bacteria |
1300 |
0.43 |
Binding ≤ 10μM
|
B1WBY8-1-E |
Histone Deacetylase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
HDA10-1-E |
Histone Deacetylase 10 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
72 |
0.53 |
Binding ≤ 10μM
|
HDA11-3-E |
Histone Deacetylase 11 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
50 |
0.54 |
Binding ≤ 10μM
|
HDAC1-3-E |
Histone Deacetylase 1 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
HDAC2-4-E |
Histone Deacetylase 2 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
921 |
0.44 |
Binding ≤ 10μM |
HDAC3-2-E |
Histone Deacetylase 3 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
HDAC4-2-E |
Histone Deacetylase 4 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
HDAC5-1-E |
Histone Deacetylase 5 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
50 |
0.54 |
Binding ≤ 10μM
|
HDAC6-2-E |
Histone Deacetylase 6 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
90 |
0.52 |
Binding ≤ 10μM
|
HDAC7-3-E |
Histone Deacetylase 7 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
HDAC8-1-E |
Histone Deacetylase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
820 |
0.45 |
Binding ≤ 10μM
|
HDAC9-3-E |
Histone Deacetylase 9 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
65 |
0.53 |
Binding ≤ 10μM
|
NCOR2-1-E |
Nuclear Receptor Corepressor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
34 |
0.55 |
Binding ≤ 10μM
|
Q5RJZ2-1-E |
Histone Deacetylase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
Q7K6A1-1-E |
Histone Deacetylase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
100 |
0.52 |
Binding ≤ 10μM
|
Q94F81-1-E |
Histone Deacetylase HD2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
50 |
0.54 |
Binding ≤ 10μM
|
Q99P97-1-E |
Histone Deacetylase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
Q9XYC7-1-E |
Histone Deacetylase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
59 |
0.53 |
Binding ≤ 10μM
|
Q9ZTP8-1-E |
Histone Deacetylase HD1B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.55 |
Binding ≤ 10μM
|
HDA10-1-E |
Histone Deacetylase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDA11-1-E |
Histone Deacetylase 11 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC1-1-E |
Histone Deacetylase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC2-1-E |
Histone Deacetylase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC3-1-E |
Histone Deacetylase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC4-1-E |
Histone Deacetylase 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC5-1-E |
Histone Deacetylase 5 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC6-1-E |
Histone Deacetylase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC7-1-E |
Histone Deacetylase 7 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC8-1-E |
Histone Deacetylase 8 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC9-1-E |
Histone Deacetylase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
Q94F81-2-E |
Histone Deacetylase HD2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
50 |
0.54 |
Functional ≤ 10μM
|
Z102015-1-O |
Plasmodium Vivax (cluster #1 Of 1), Other |
Other |
170 |
0.50 |
Functional ≤ 10μM
|
Z103205-2-O |
A431 (cluster #2 Of 4), Other |
Other |
4200 |
0.40 |
Functional ≤ 10μM
|
Z103348-2-O |
NCI-H2122 (cluster #2 Of 2), Other |
Other |
7500 |
0.38 |
Functional ≤ 10μM
|
Z50136-2-O |
Plasmodium Falciparum (isolate FcB1 / Columbia) (cluster #2 Of 3), Other |
Other |
820 |
0.45 |
Functional ≤ 10μM
|
Z50425-5-O |
Plasmodium Falciparum (cluster #5 Of 22), Other |
Other |
800 |
0.45 |
Functional ≤ 10μM
|
Z80054-4-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
8100 |
0.38 |
Functional ≤ 10μM
|
Z80064-7-O |
CCRF-CEM (T-cell Leukemia) (cluster #7 Of 9), Other |
Other |
950 |
0.44 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2120 |
0.42 |
Functional ≤ 10μM
|
Z80156-4-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #4 Of 12), Other |
Other |
1200 |
0.44 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
2400 |
0.41 |
Functional ≤ 10μM
|
Z80166-4-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #4 Of 12), Other |
Other |
2000 |
0.42 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
750 |
0.45 |
Functional ≤ 10μM
|
Z80224-6-O |
MCF7 (Breast Carcinoma Cells) (cluster #6 Of 14), Other |
Other |
8500 |
0.37 |
Functional ≤ 10μM
|
Z80244-1-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #1 Of 7), Other |
Other |
5000 |
0.39 |
Functional ≤ 10μM
|
Z80322-1-O |
NCI-H358 (Lung Carcinama Cells) (cluster #1 Of 2), Other |
Other |
2500 |
0.41 |
Functional ≤ 10μM
|
Z80390-3-O |
PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
6500 |
0.38 |
Functional ≤ 10μM
|
Z80418-9-O |
RAW264.7 (Monocytic-macrophage Leukemia Cells) (cluster #9 Of 9), Other |
Other |
760 |
0.45 |
Functional ≤ 10μM
|
Z80475-2-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #2 Of 3), Other |
Other |
2100 |
0.42 |
Functional ≤ 10μM
|
Z80493-3-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #3 Of 6), Other |
Other |
2500 |
0.41 |
Functional ≤ 10μM
|
Z80513-1-O |
SQ20B (cluster #1 Of 1), Other |
Other |
3000 |
0.41 |
Functional ≤ 10μM
|
Z80514-1-O |
St-4 (Stomach Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
5200 |
0.39 |
Functional ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 11), Other |
Other |
868 |
0.45 |
Functional ≤ 10μM
|
Z80838-1-O |
EOL1 (Eosinophilic Cells) (cluster #1 Of 1), Other |
Other |
1000 |
0.44 |
Functional ≤ 10μM
|
Z80857-1-O |
Friend Leukemia Cell Line (cluster #1 Of 2), Other |
Other |
990 |
0.44 |
Functional ≤ 10μM
|
Z80874-3-O |
CEM (T-cell Leukemia) (cluster #3 Of 7), Other |
Other |
1900 |
0.42 |
Functional ≤ 10μM
|
Z80877-1-O |
NCI-H1299 (Non-small Cell Lung Carcinoma) (cluster #1 Of 2), Other |
Other |
7240 |
0.38 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2060 |
0.42 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
900 |
0.45 |
Functional ≤ 10μM
|
Z81020-4-O |
HepG2 (Hepatoblastoma Cells) (cluster #4 Of 8), Other |
Other |
9300 |
0.37 |
Functional ≤ 10μM
|
Z81024-2-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #2 Of 8), Other |
Other |
3448 |
0.40 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
2600 |
0.41 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2300 |
0.42 |
Functional ≤ 10μM
|
Z81170-3-O |
LNCaP (Prostate Carcinoma) (cluster #3 Of 5), Other |
Other |
580 |
0.46 |
Functional ≤ 10μM
|
Z81184-5-O |
LOX IMVI (Melanoma Cells) (cluster #5 Of 5), Other |
Other |
1300 |
0.43 |
Functional ≤ 10μM
|
Z81245-4-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #4 Of 6), Other |
Other |
1900 |
0.42 |
Functional ≤ 10μM
|
Z81247-6-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #6 Of 9), Other |
Other |
460 |
0.47 |
Functional ≤ 10μM
|
Z81252-6-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #6 Of 11), Other |
Other |
2200 |
0.42 |
Functional ≤ 10μM
|
Z81280-3-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #3 Of 3), Other |
Other |
3480 |
0.40 |
Functional ≤ 10μM
|
Z81281-4-O |
NCI-H23 (Non-small Cell Lung Carcinoma Cells) (cluster #4 Of 5), Other |
Other |
383 |
0.47 |
Functional ≤ 10μM
|
Z81283-1-O |
NCI-H522 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
832 |
0.45 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.46 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
3900 |
0.40 |
Functional ≤ 10μM
|
Z80957-2-O |
HMEC (Microvascular Endothelial Cells) (cluster #2 Of 2), Other |
Other |
1300 |
0.43 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.47 |
4.41 |
-18.87 |
3 |
5 |
0 |
78 |
264.325 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.92 |
6.98 |
-47.63 |
2 |
5 |
0 |
74 |
363.442 |
4 |
↓
|
Hi
High (pH 8-9.5)
|
4.92 |
6.58 |
-44.4 |
1 |
5 |
-1 |
73 |
362.434 |
4 |
↓
|
Hi
High (pH 8-9.5)
|
4.92 |
6.42 |
-14.46 |
2 |
5 |
0 |
71 |
363.442 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
71 |
0.45 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
71 |
0.45 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
71 |
0.45 |
Functional ≤ 10μM
|
Z80017-2-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
570 |
0.40 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2300 |
0.36 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
990 |
0.38 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
98 |
0.45 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
3800 |
0.34 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
98 |
0.45 |
Functional ≤ 10μM
|
Z80493-3-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #3 Of 6), Other |
Other |
980 |
0.38 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
530 |
0.40 |
Functional ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
510 |
0.40 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
580 |
0.40 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
190 |
0.43 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
189 |
0.43 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.34 |
-0.53 |
-51.34 |
2 |
4 |
1 |
46 |
294.378 |
4 |
↓
|
|
|
Analogs
-
13361676
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.85 |
11.85 |
-12.99 |
1 |
6 |
0 |
66 |
401.466 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
400 |
0.26 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
180 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.37 |
10.97 |
-14.35 |
1 |
7 |
0 |
75 |
471.435 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.30 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
530 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.08 |
1.15 |
-12.72 |
1 |
6 |
0 |
65 |
421.884 |
6 |
↓
|
|
|
Analogs
-
34858628
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
750 |
0.28 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2600 |
0.25 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.22 |
2.23 |
-13.05 |
1 |
6 |
0 |
65 |
415.493 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 15 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCNB1-1-E |
G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CCNB2-1-E |
G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CCNB3-1-E |
G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CLK3-1-E |
Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
41 |
0.41 |
Binding ≤ 10μM
|
CSK21-1-E |
Casein Kinase II Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1 |
0.50 |
Binding ≤ 10μM
|
DAPK3-1-E |
Death-associated Protein Kinase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
17 |
0.44 |
Binding ≤ 10μM
|
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
55 |
0.41 |
Binding ≤ 10μM
|
HIPK3-1-E |
Homeodomain-interacting Protein Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
45 |
0.41 |
Binding ≤ 10μM
|
PIM1-1-E |
Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
46 |
0.41 |
Binding ≤ 10μM
|
TBK1-1-E |
Serine/threonine-protein Kinase TBK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
35 |
0.42 |
Binding ≤ 10μM
|
Z103203-2-O |
A375 (cluster #2 Of 3), Other |
Other |
3900 |
0.30 |
Functional ≤ 10μM
|
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
5300 |
0.30 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
8900 |
0.28 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
2100 |
0.32 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
3000 |
0.31 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
2200 |
0.32 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2500 |
0.31 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
4700 |
0.30 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
6400 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.14 |
10.5 |
-55.54 |
1 |
5 |
-1 |
78 |
348.769 |
3 |
↓
|
Hi
High (pH 8-9.5)
|
1.84 |
5.03 |
-92.09 |
7 |
8 |
2 |
122 |
456.497 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
10000 |
0.25 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.91 |
6.32 |
-49.37 |
2 |
6 |
0 |
84 |
393.468 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
4.91 |
5.92 |
-51.23 |
1 |
6 |
-1 |
82 |
392.46 |
5 |
↓
|
|